Accurate medical treatment of traditional inefficient treatment, tumor genetic testing is about to break out
The ineffectiveness of traditional therapies for the treatment of complex diseases, especially malignant tumors, has led to the development of precision medicine . Gene sequencing in the field of cancer is the most important component of precision medicine , including susceptibility gene detection, early screening, disease diagnosis, personalized medication guidance, follow-up and efficacy evaluation, etc., and is expected to reach the market scale of 100 billion in the future.
Advances in genetic testing technology, tumor genetic testing is welcoming
The popularity of genetic testing and technological breakthroughs are the main factors driving the rapid growth of the market. On the one hand, the relationship between more and more disease pre-gene mutations has been proven, and the accuracy of genetic testing is increasing year by year. On the other hand, with the maturity of sequencing technology, the decline in sequencing costs will increase the penetration rate of gene sequencing services, and thus promote the rapid development of the market.
Tumors will become the largest application market for gene sequencing. On the one hand, with the aging of China, environmental pollution and food safety continue to deteriorate, the incidence of cancer is increasing year by year; on the other hand, the individual differences of cancer are large, the application of traditional treatment methods is very limited, and tumor gene detection can provide effective Medication guidance.
The gene sequencing market will reach a total size of 200 US dollars, and the tumor gene sequencing market will soon be out. According to BBC Research, the global gene sequencing market will be 790 million US dollars in 2007, and the market size will be 4.5 billion US dollars in 2013. The global genetic sequencing market is expected in 2018. The scale will reach 11 billion US dollars, with a compound annual growth rate of 29%.
According to Illumina's estimates, the market for gene sequencing services will have a capacity of $20 billion over the next few years, including $12 billion in oncology, $5 billion in life sciences, $2 billion in fertility and genetic health, and $1 billion in other applications. At this stage, domestically sequenced clinical services are used more in prenatal testing, and the tumor gene sequencing market is about to break out.
Invest in the whole industry chain of genetic testing, focusing on the layout of tumor genetic testing
It is recommended to focus on upstream companies with sequencing instrument and reagent consumable production capacity, midstream sequencing service providers that have hospital channel resources, and downstream bioinformatics companies with large sample acquisition and big data analysis capabilities.
From the perspective of sequencing instrument and reagent consumable production capacity, it is recommended to pay attention to: Zixin Pharmaceutical, Daan Gene and Changhong Technology; from the perspective of channel possession, it is recommended to pay attention to: Daan Gene, Dean Diagnostics, Hokuriku Pharmaceutical, Anke Biological, new open source, Xiqiao science and Zhongyuan Concord; from the perspective of big data analysis capabilities, recommended attention: Rongzhilian. Focus on the layout of listed companies in the field of tumor gene detection, focusing on their unique competitive advantages.
Fruit powder is a food made of apple powder, citric acid, white sugar, malic acid mixed acid, vitamin C, powder, tetraarachidene powder, etc., which are processed, inspected and packaged in a certain proportion. It can promote digestion and increase immunity. Vinegar powder and arachidonic acid powder can be used to prevent and control harm and other places, which can better promote human health and reduce the occurrence of cardiovascular diseases.
We are an industry and trade integrated enterprise in China. Our company was established in 2010 and has 12 years of export experience and production experience. Our company has unique advantages in production of Organic Extract, because our Plant Extract is come from our own plant extracting, cultivation at the same time, our production of Herbal Extract from our local, our factory is located in xi 'an, China, where climate conditions are beneficial to plant growth, at the same time good plant diversity. Our company is also a leading China Leading Manufacturers And Suppliers Of APIs Raw, because we have professional Chinese Api Raw Material suppliers, we have set up a professional production workshop, standard production equipment, high-quality technical personnel.
Fruit extract powder ,Pine Bark Benefits,Kava Extract Buy Online,Bitter Chrysanthemum Extract Powder,Roselle Extract Active Ingredients
Xi'an Henrikang Biotech Co.,Ltd , https://www.henruikangbio.com